AN IMMUNOGENIC VACCINE AGAINST THE HCV AND/OR HBV
The invention concerns a vaccine containing determinant 'a' of the HBsAg protein of the HBV virus, subtype adw2, and region 412-425 of E2 envelope glycoprotein of the HCV. The invention further concerns isolated chimeric protein in the form of vaccine, a combination containing chimeric pro...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | English Polish |
Published |
15.06.2020
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The invention concerns a vaccine containing determinant 'a' of the HBsAg protein of the HBV virus, subtype adw2, and region 412-425 of E2 envelope glycoprotein of the HCV. The invention further concerns isolated chimeric protein in the form of vaccine, a combination containing chimeric protein, and a method of obtaining the vaccine. Furthermore, the invention concerns a composition containing chimeric protein and an expression vector. |
---|---|
Bibliography: | Application Number: PL20160705838T |